Sexual outcomes of aromatase inhibitor therapy in women with breast cancer: time for intervention

被引：6
作者：
Bradford, Andrea [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA
来源：
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2013年 / 20卷 / 02期
关键词：
HEALTH; DYSFUNCTION; PREVENTION; PREDICTORS; TAMOXIFEN; DISTRESS; DESIRE;
D O I：
10.1097/gme.0b013e31828094b0
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：128 / 129
页数：2
相关论文
共 18 条
[1]   Sexual dysfunction after premenopausal Stage I and II breast cancer: Do androgens play a role? [J].
Alder, Judith ;
Zanetti, Rosanna ;
Wight, Edward ;
Urech, Corinne ;
Fink, Nadine ;
Bitzer, Johannes .
JOURNAL OF SEXUAL MEDICINE, 2008, 5 (08) :1898-1906
[2]   Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer [J].
Baumgart, Juliane ;
Nilsson, Kerstin ;
Evers, Anneli Stavreus ;
Kallak, Theodora Kunovac ;
Poromaa, Inger Sundstrom .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2013, 20 (02) :162-168
[3]   Effect of endocrine treatment on sexuality in premenopausal breast cancer patients:: A prospective randomized study [J].
Berglund, G ;
Nystedt, M ;
Bolund, C ;
Sjödén, PO ;
Rutquist, LE .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (11) :2788-2796
[4]   Simple Strategies for Vaginal Health Promotion in Cancer Survivors [J].
Carter, Jeanne ;
Goldfrank, Deborah ;
Schover, Leslie R. .
JOURNAL OF SEXUAL MEDICINE, 2011, 8 (02) :549-559
[5]   Health-related quality of life and tamoxifen in breast cancer prevention: A report from the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].
Day, R ;
Ganz, PA ;
Costantino, JP ;
Cronin, WM ;
Wickerham, DL ;
Fisher, B .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) :2659-2669
[6]   Tamoxifen for the prevention of breast cancer: Psychosocial impact on women participating in two randomized controlled trials [J].
Fallowfield, L ;
Fleissig, A ;
Edwards, R ;
West, A ;
Powles, TJ ;
Howell, A ;
Cuzick, J .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (07) :1885-1892
[7]   Predictors of sexual health in women after a breast cancer diagnosis [J].
Ganz, PA ;
Desmond, KA ;
Belin, TR ;
Meyerowitz, BE ;
Rowland, JH .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) :2371-2380
[8]   Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors [J].
Kendall, A ;
Dowsett, M ;
Folkerd, E ;
Smith, I .
ANNALS OF ONCOLOGY, 2006, 17 (04) :584-587
[9]   Aromatase inhibitors and breast cancer prevention [J].
Litton, Jennifer Keating ;
Arun, Banu K. ;
Brown, Powel H. ;
Hortobagyi, Gabriel N. .
EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (03) :325-331
[10]   Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer [J].
Loprinzi, CL ;
AbuGhazaleh, S ;
Sloan, JA ;
vanHaelstPisani, C ;
Hammer, AM ;
Rowland, KM ;
Law, M ;
Windschitl, HE ;
Kaur, JS ;
Ellison, N .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :969-973
12